Affordable Access

deepdyve-link
Publisher Website

Population prevalence of Down's syndrome in the United Kingdom.

Authors
  • Alexander, M1
  • Ding, Y2
  • Foskett, N1
  • Petri, H3
  • Wandel, C4
  • Khwaja, O5
  • 1 Roche Products Limited, United Kingdom of Great Britain and Northern Ireland. , (United Kingdom)
  • 2 Genesis Research Limited, USA.
  • 3 Petri Consulting Ltd, United Kingdom of Great Britain and Northern Ireland. , (United Kingdom)
  • 4 Roche Product Development, Switzerland. , (Switzerland)
  • 5 Roche Pharmaceutical Research and Early Development, Switzerland. , (Switzerland)
Type
Published Article
Journal
Journal of intellectual disability research : JIDR
Publication Date
Sep 01, 2016
Volume
60
Issue
9
Pages
874–878
Identifiers
DOI: 10.1111/jir.12277
PMID: 27018385
Source
Medline
Keywords
License
Unknown

Abstract

A relative peak prevalence of DS at age 40-55 years may be attributed to the combined effects of a rise in life expectancy and the still limited availability of selective abortion.

Report this publication

Statistics

Seen <100 times